Faculty profile
Marlys KOSCHINSKY
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Windsor directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Lipoprotein(a) as a therapeutic target in cardiovascular disease.
Expert opinion on therapeutic targets · 2014 · first author
Latest funding
- $228,000
Synthesis and Assembly of Lipoprotein(a)
NSERC · 2015 · Principal investigator
- $284,381
The role of oxidized phospholipids in the pathogenicity of lipoprotein(a)
CIHR · 2012 · Nominated PI
- $3,000
Preventing cardiovascular disease: lifestyle modification, drug intervention, or genetic determination?
CIHR · 2012 · Nominated PI
1 publications.
Lipoprotein(a) as a therapeutic target in cardiovascular disease.
Koschinsky M, Boffa M
Synthesis and Assembly of Lipoprotein(a)
Principal investigators: Koschinsky, Marlys
The role of oxidized phospholipids in the pathogenicity of lipoprotein(a)
Principal investigators: KOSCHINSKY, Marlys L
Keywords: Apolipoprotein(A); Atherosclerosis; Cell Signaling; Gene Expression; Inflammation; Lipoprotein(A); Macrophages; Monocytes; Oxidized Phospholipids; Vascular Endothelial Cells
Preventing cardiovascular disease: lifestyle modification, drug intervention, or genetic determination?
Principal investigators: KOSCHINSKY, Marlys L
Keywords: Cafe Scientifique; Cardiovascular Disease; Diabetes; Drug Therapy; Genetic Risk; Lifestyle Modification; Myocardial Infarction; Nutrition; Panel Discussion; Stroke
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.